Hepatitis A Vaccine and Sexual Transmission in MSM
Hepatitis A is usually framed as a food-and-water disease — and most US cases are. But since 2016-2017, large outbreaks of hepatitis A among MSM (men who have sex with men) in US cities have made hep A a recognized sexual health issue.
The vaccine is highly effective. The infection is sometimes serious. Here's the practical picture.
The short answer
- What it is: A viral liver infection caused by hepatitis A virus (HAV)
- How it spreads: Fecal-oral contact (eating contaminated food, person-to-person contact involving fecal contamination)
- In MSM specifically: Spread through sexual contact involving anal-oral contact, fingering, rimming
- Vaccine: Highly effective, 2-dose schedule (Havrix, Vaqta), 6 months apart; one dose gives substantial protection
- Severity: Most cases recover fully but can cause serious illness, especially in older adults or those with chronic liver disease
- No chronic infection (unlike hep B and C)
Why hep A matters for MSM in 2026
The outbreaks
- 2016-2017: Outbreaks in US cities — San Diego, Detroit, others
- Spread primarily among MSM with multiple anonymous partners
- Persistent low-level circulation through 2018-2026
- Some cities continue active outbreaks
- Hospitalization rates ~50%; some deaths reported
Why sexual transmission
- Fecal contact during anal sex, rimming (oral-anal), fingering
- Hand-to-hand or hand-to-mouth contamination after sexual contact
- Even small amounts of feces can transmit virus
- Pre-symptomatic shedding means people don't know they're infectious
Risk factors
- MSM with multiple partners — highest current US risk group
- People experiencing homelessness — major US outbreak driver since 2017
- People who use injection drugs
- Healthcare workers
- Travel to high-prevalence countries
- Chronic liver disease patients (especially severe disease if infected)
How hep A presents
Incubation
- 15-50 days from exposure to symptoms
- Average ~28 days
Symptoms (in adults — children often asymptomatic)
- Fatigue (often the first symptom)
- Nausea, vomiting
- Decreased appetite
- Abdominal pain (right upper quadrant)
- Dark urine
- Pale stools
- Jaundice (yellowing of skin/eyes) — usually 1-2 weeks after first symptoms
- Joint pain
- Low-grade fever
Severity
- Most cases resolve in 2-4 weeks
- Some cases prolonged (6+ months)
- Hospitalization rate ~25-50% in adult outbreaks
- Acute liver failure rare but possible (especially with chronic liver disease)
- Deaths uncommon but documented
No chronic hep A
- Unlike hep B and hep C, hep A doesn't become chronic
- Once recovered, lifelong immunity
Diagnosis
- HAV IgM antibody: Positive during acute infection
- HAV total antibody (or IgG): Positive after recovery or vaccination
- Liver enzymes typically very elevated (ALT often >1000)
Treatment
- Supportive care — there's no specific antiviral for hep A
- Rest, hydration, nutrition
- Avoid alcohol entirely during illness
- Avoid medications that strain liver (acetaminophen at high doses, certain antibiotics)
- Avoid spreading: scrupulous hand hygiene, no preparing food for others during illness
- Hospital admission if dehydration or severe symptoms
The hepatitis A vaccine
Approved vaccines
- Havrix (GSK) — 2-dose schedule
- Vaqta (Merck) — 2-dose schedule
- Twinrix (combined hep A + hep B) — 3-dose schedule
Schedule
- Dose 1: at day 0
- Dose 2: at 6-12 months (depending on brand)
- After dose 2, protection > 95%
- After dose 1 alone: ~95% protection for several years
Effectiveness
- One dose gives substantial protection (good for outbreak response)
- Two doses provide long-term immunity (20+ years, possibly lifelong)
- Even single dose works well in outbreak scenarios
Side effects
- Injection-site soreness
- Mild fatigue, headache
- Rarely fever
- Allergic reactions very rare
Cost and access
- Covered by most insurance
- Affordable Care Act coverage in many cases
- Public health departments often provide free vaccine in outbreak areas
- Sexual health clinics often have it
Who should get vaccinated
Current recommendations include:
- All children — routine childhood vaccination since 2006 (vaccinate all children by 23 months)
- MSM — recommended for all MSM, especially with multiple partners
- People experiencing homelessness
- People who use illicit drugs (injection or non-injection)
- Travelers to areas with hep A
- People with chronic liver disease
- People with HIV (especially with multiple partners)
- Household contacts of someone with hepatitis A
- People in outbreak settings
If you're in any of these groups and unsure of vaccine status — ask your provider.
What if I've been exposed
Post-exposure prophylaxis (PEP) for hep A
- Within 14 days of exposure:
- Single hep A vaccine dose (preferred for healthy adults 1-40)
- Or hep A immune globulin (preferred for very young, very old, or chronic liver disease patients)
- Best given as soon as possible
After exposure
- Symptoms can take 15-50 days
- Get vaccinated promptly if not already vaccinated
- Monitor for symptoms
- Avoid food preparation for others until cleared
- Get tested if symptoms develop
In current outbreaks
- US is in a slowly waning multi-year outbreak that started 2016-2017
- Vaccination is being aggressively pushed
- Some local health departments have mass vaccination campaigns
How to know if you're already immune
- HAV total antibody (anti-HAV IgG) — positive = immune (from past infection or vaccination)
- Test if uncertain
- Vaccinate if negative
Hep A in pregnancy
- Vaccine is safe in pregnancy (inactivated, non-replicating)
- Recommended for pregnant women at risk
- Hep A during pregnancy isn't typically severe but may be debilitating
What MSM should specifically do
- Get vaccinated if not already (2 doses, 6 months apart)
- Wash hands thoroughly after sex
- Avoid food preparation for others if you've been potentially exposed and have any symptoms
- Bring barrier methods for rimming (dental dam) if you choose
- Get tested if symptoms develop
- In outbreak settings: check with local health department for additional advice
Other diseases hep A vaccination covers
- Just hep A
- The Twinrix combo also covers hep B
- Doesn't affect HIV, herpes, HPV, etc.
What if I had hep A in childhood?
- Lifelong immunity
- No need to vaccinate
- Antibody test can confirm
Hep A vs hep B vs hep C — quick distinction
| Hep A | Hep B | Hep C | |
|---|---|---|---|
| Spread | Fecal-oral (food, sex involving fecal contact) | Blood, sex, vertical | Blood-blood (mostly needle sharing) |
| Chronic? | No | Yes (some adults) | Yes (most adults) |
| Vaccine? | Yes (2 doses) | Yes (2-3 doses) | No vaccine |
| Cure? | No needed; resolves | No cure but suppressible | YES (95%+ with DAAs) |
See hepatitis B vaccine and hepatitis C cure for those.
Bottom line
Hepatitis A in 2026 is:
- Preventable with 2-dose vaccine (highly effective)
- Sexually transmissible through anal-oral contact
- A real concern for MSM during ongoing US outbreaks
- Treatable supportively (no antiviral; vast majority recover fully)
- No chronic phase (unlike hep B and C)
If you're MSM and haven't been vaccinated for hep A — get it. Two shots, 6 months apart, very effective. The vaccine is widely available, covered by most insurance, and could prevent a really uncomfortable illness.
For more on hepatitis and prevention, see hepatitis B vaccine schedule, hepatitis C cure, doxyPEP, and HPV vaccine for adults over 26.
